Novo Nordisk launches weight loss drug ‘Wegovy' in India
One-weekly injectable semaglutide, Wegovy is the first and only weight management medication in India indicated for both long-term chronic weight management and reduction in risk of major adverse cardiovascular events in people living with the condition, said the company in a statement.
It is being made available in five dosing strengths with an easy-to-use pen device which does away the use of syringes; therefore, can be self-administered at home.
India has the third highest number of people living with overweight and obesity. Alarmingly, obesity is associated with over 200 diseases, including cardiovascular diseases, certain types of cancer, and type 2 diabetes.
According to the clinical trials, the drug is shown to have 20% or more weight reduction in at least 1 in 3 individuals when used along with lifestyle interventions comprising reduced calorie diet and increased physical activity. Also, a 20% reduction in the risk of major adverse cardiovascular events, such as stroke, heart attack, and cardiovascular disease related death, when used on top of standard of care in people with established cardiovascular disease and overweight or obesity. Phase-III trial was conducted in about 3500 participants in India.
'Obesity is not just a personal health concern—it is a chronic disease and a national epidemic that India cannot afford to ignore. Recognising this, we are proud to announce that we are bringing Wegovy to Indians as a transformative and evidence-based therapeutic solution with the convenience of a world-class, state-of-the-art pen device. Additionally, we have an India-specific price with the benefit of same price for the first three dosing strengths,' said Vikrant Shrotriya, managing director, Novo Nordisk India, during the launch.
According to the company statement, wegovy will be available in a once-weekly innovative pen device in five dose strengths – 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and a maintenance dosing of 2.4 mg.
The price for 0.25, 0.5, and 1 mg doses is ₹ 17345 a month, and for 1.7 and 2.4mg it is ₹ 24280 and ₹ 26050 a month respectively.
'While deciding the pricing, our aim was to ensure that the real benefit gets accrued without burning a hole in the pocket. It's being launched pan-India, and it is prescription only drug,' said Shrotriya.
The drug acts on key areas of the brain involved in appetite regulation and food intake thereby reducing hunger, improving satiety and reducing cravings for food, eventually inducing weight-loss, said the company statement. It also improves insulin resistance and has a beneficial effect on reduction of cardiometabolic events and risk factors.
'Semaglutide is the active ingredient in… Wegovy… It is indicated for weight management and reducing the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight.'
According to the doctors, the drug needs to be taken under medical supervision only.
'Anyone prescribed the drug has to be on a weight management programme. Indications for use include a body mass index of 30 even without comorbidities, and 27 with comorbidities. Dosage will depend on patient to patient— for weightloss, the need would be for a higher dose, and lower dose would be needed for those put on weight maintenance,' said Dr Ambrish Mithal, chairman and head of endocrinology and diabetes, Max Healthcare.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
8 hours ago
- Time of India
US lawmakers press FDA to target knockoff weight-loss drugs
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks. On Friday, a group of more than 80 bipartisan lawmakers asked the US Food and Drug Administration to stop counterfeit and copycat versions of GLP-1 drugs like Wegovy and Zepbound from flooding the market-a problem that emerged over the last year. Explore courses from Top Institutes in Please select course: Select a Course Category Cybersecurity MCA Data Science Degree Leadership PGDM Public Policy Operations Management others Others Product Management healthcare Digital Marketing MBA Technology Project Management CXO Finance Artificial Intelligence Healthcare Data Analytics Management Design Thinking Data Science Skills you'll gain: Duration: 10 Months MIT xPRO CERT-MIT xPRO PGC in Cybersecurity Starts on undefined Get Details "We are concerned about recent reports revealing a surge in illegal and counterfeit anti-obesity medications," they wrote in a letter to FDA commissioner Marty Makary. "Undoubtedly, illegal counterfeit medications pose an increased risk to patient safety with sometimes fatal consequences." by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo The group-spearheaded by Representatives Richard Hudson of North Carolina and Herb Conaway of New Jersey-asked the agency to ramp up enforcement over illegally imported weight-loss drugs. They suggested issuing warning letters and better monitoring non-compliant online retailers and so-called compounding pharmacies that sell the medicines. The lawmakers also said the FDA should work in tandem with US Customs and Border Patrol agents to stop Chinese entities from shipping unsafe weight-loss drugs into the US. They requested an update on the FDA's efforts by July 30, given the "urgency" of the situation. Live Events A spokesperson for the FDA said the agency will work with the US Department of Health and Human Services to provide a "complete and thorough" response to the issues raised in the lawmakers' letter. "Any effort to undermine America's supply of safe medicines is an issue that FDA takes seriously," the spokesperson said. "And we are deeply committed to strengthening the oversight of imported products at US ports of entry." In recent years, the popularity of GLP-1 drugs has led to an explosion of copycats and counterfeits made by companies seeking to capitalise on the hype. State-licensed pharmacies were temporarily allowed to make copies of the drugs during a supply shortage but are no longer permitted to do so after Novo Nordisk and Eli Lilly boosted production. Still, some pharmacies have refused to wind down their operations while others have pivoted to selling the drugs in lower doses in order to avoid regulatory scrutiny. Counterfeit drugs are made by unregistered entities typically using illegally imported ingredients. As recently as April, there continue to be instances when counterfeit Ozempic pens covertly enter the drug supply chain undetected. Some patients are also purchasing ingredients directly from online sellers in an attempt to make the drugs themselves at home. In both cases, the medications don't go through the same rigorous approval process as brand-name drugs made by Novo and Lilly. Experts worry the lack of oversight is putting patients at risk. The FDA has said it's aware of hospitalisations potentially linked to the copycat drugs, but that adverse events are likely being underreported. "We support the bi-partisan call for the FDA to crack down on counterfeit and illegally sold weight-loss drugs," said a spokesperson for Hims & Hers Health, one of the telehealth firms that sells compounded GLP-1s. "We appreciate lawmakers' recognition that legitimate compounded medications dispensed by state-regulated pharmacies are not counterfeit. Patient safety must always come first." Novo and Lilly have discouraged consumers from using compounded and counterfeit products, including suing telehealth firms that sell the copycat versions and working with border agents to seize illegal shipments.
Mint
11 hours ago
- Mint
Lawmakers Press FDA to Target Knockoff Weight-Loss Drugs
(Bloomberg) -- Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks. On Friday, a group of more than 80 bipartisan lawmakers asked the US Food and Drug Administration to stop counterfeit and copycat versions of GLP-1 drugs like Wegovy and Zepbound from flooding the market — a problem that emerged over the last year. 'We are concerned about recent reports revealing a surge in illegal and counterfeit anti-obesity medications,' they wrote in a letter to FDA Commissioner Marty Makary. 'Undoubtedly, illegal counterfeit medications pose an increased risk to patient safety with sometimes fatal consequences.' The group — spearheaded by Representatives Richard Hudson of North Carolina and Herb Conaway of New Jersey — asked the agency to ramp up enforcement over illegally imported weight-loss drugs. They suggested issuing warning letters and better monitoring non-compliant online retailers and so-called compounding pharmacies that sell the medicines. The lawmakers also said the FDA should work in tandem with US Customs and Border Patrol agents to stop Chinese entities from shipping unsafe weight-loss drugs into the US. They requested an update on the FDA's efforts by July 30, given the 'urgency' of the situation. A spokesperson for the FDA said the agency will work with the US Department of Health and Human Services to provide a 'complete and thorough' response to the issues raised in the lawmakers' letter. 'Any effort to undermine America's supply of safe medicines is an issue that FDA takes seriously,' the spokesperson said. 'And we are deeply committed to strengthening the oversight of imported products at US ports of entry.' In recent years, the popularity of GLP-1 drugs has led to an explosion of copycats and counterfeits made by companies seeking to capitalize on the hype. State-licensed pharmacies were temporarily allowed to make copies of the drugs during a supply shortage, but are no longer permitted to do so after Novo Nordisk A/S and Eli Lilly & Co. boosted production. Still, some pharmacies have refused to wind down their operations while others have pivoted to selling the drugs in lower doses in order to avoid regulatory scrutiny. Counterfeit drugs are made by unregistered entities typically using illegally imported ingredients. As recently as April, there continue to be instances when counterfeit Ozempic pens covertly enter the drug supply chain undetected. Some patients are also purchasing ingredients directly from online sellers in an attempt to make the drugs themselves at home. In both cases, the medications don't go through the same rigorous approval process as brand-name drugs made by Novo and Lilly. Experts worry the lack of oversight is putting patients at risk. The FDA has said it's aware of hospitalizations potentially linked to the copycat drugs, but that adverse events are likely being underreported. 'We support the bi-partisan call for the FDA to crack down on counterfeit and illegally sold weight-loss drugs,' said a spokesperson for Hims & Hers Health Inc., one of the telehealth firms that sells compounded GLP-1s. 'We appreciate lawmakers' recognition that legitimate compounded medications dispensed by state-regulated pharmacies are not counterfeit. Patient safety must always come first.' Novo and Lilly have discouraged consumers from using compounded and counterfeit products, including suing telehealth firms that sell the copycat versions and working with border agents to seize illegal shipments. Under the Biden administration, the companies repeatedly urged the FDA to take action, but the agency mostly limited its actions to issuing consumer warnings — even as its top drug official publicly acknowledged safety concerns. Under the Trump administration, the HHS has also focused more heavily on other issues, such as banning food dyes and examining vaccine schedules. Meanwhile, lawmakers are ramping up their calls for action. State attorneys and other lawmakers have sent letters to the FDA and Federal Trade Commission advocating for greater transparency around the treatments and more scrutiny around marketing practices. (Updates with statement from FDA in sixth and seventh paragraphs.) More stories like this are available on
Time of India
13 hours ago
- Time of India
Doctors declared her dead. His family urged him to leave her, but he proved 'true love does not walk away.' Here's how
The doctors had officially declared her dead. But it was her loving husband who insisted that she had not yet left the living and stayed by her for 30 days, bathing and feeding her diligently. In this crisis, Varinder proved he was here to support her in sickness and health, as he had once vowed to when they tied the knot. Life had been gentle and fulfilling for a woman who shared her heartfelt story through Humans of Bombay. Married to Varinder through an arranged setup, she remembered falling in love the moment she saw his photograph. Without any hesitation, she told her father about her feelings, and the two families soon united the couple in marriage. Their routine was simple but fulfilling—daily visits to the temple, leisurely walks holding hands, and raising their two children with love and care. For a long time, life felt perfect—complete in every sense. Explore courses from Top Institutes in Please select course: Select a Course Category Technology Healthcare Leadership Operations Management CXO Finance Product Management Digital Marketing Others others Management Data Analytics Degree MBA Design Thinking Artificial Intelligence Data Science MCA Cybersecurity Data Science Project Management healthcare Public Policy PGDM Skills you'll gain: Duration: 12 Weeks MIT xPRO CERT-MIT XPRO Building AI Prod India Starts on undefined Get Details But everything changed in an instant on March 11, 2012. That day, as she was descending a flight of stairs, a sudden stumble left one of her legs feeling oddly numb. Believing it to be a sign of tiredness, she initially ignored the sensation. However, Varinder was concerned and took her to consult a doctor. Even the medical expert dismissed it as something minor. But what followed the next morning changed their lives forever. An Unexpected Diagnosis As she attempted to get out of bed the following day, her body gave way—she collapsed and realized she could no longer feel her leg. Alarmed, she screamed for Varinder, who immediately rushed her to the hospital. After a series of tests, doctors diagnosed her with Guillain-Barré Syndrome ( GBS ), a rare but life-threatening neurological disorder. The situation quickly spiraled into a nightmare. Her body became a battleground of pain and paralysis. Needles pierced her skin constantly, and eventually, even the simple act of breathing turned into a struggle. Varinder, helpless but determined, repeatedly pleaded with medical staff to help his ailing wife. But no treatment seemed to work. Then came the worst moment—her consciousness faded, and everything went dark. A Husband's Refusal to Let Go When she regained awareness, she found herself in a different hospital. Varinder explained what had transpired during her blackout. The previous hospital had administered an incorrect dosage of medication, nearly ending her life. The attending doctors had declared her dead, certain there was nothing more they could do. But Varinder, unwilling to accept their finality, took matters into his own hands. For 35 relentless minutes, he performed CPR on her, refusing to surrender to fate. Miraculously, his efforts succeeded — she came back to life. This was not just an act of love; it was a battle for survival that he chose to fight alone when the world had already given up. Standing Strong Amid Pressure and Pain Throughout her hospital stay, Varinder remained a constant presence. Despite immense pressure from relatives and even some medical staff suggesting that he abandon her—saying she would not recover and it was better to send her back to her maternal home—Varinder refused to budge. Every single day, he remained by her side. He bathed her gently each morning, ensured she received every meal on time, and held her hands whenever she underwent painful treatments. His dedication went far beyond duty—it was a living embodiment of the marital vows they had taken years ago. A Caregiver's Journey at Home After an entire month of intensive care, she was finally discharged. But the journey to recovery was far from over. At home, Varinder took on multiple roles—caregiver, father, homemaker, and breadwinner. He looked after the children, managed household chores, and continued his job, all while tending to her every need with compassion and care. To her, it felt like being reborn. Varinder gave her a second life, one that was fragile yet filled with love and meaning. A Testament to Enduring Love Thirteen years have passed since that harrowing ordeal. Though she now walks with a limp and is a bit slower than she used to be, the love between them remains unchanged. In fact, it has only grown deeper. Hand in hand, they still go on walks—just like they used to—a powerful symbol of a love that defied death and despair. In every sense, Varinder lived up to the promise made during their wedding: to be there in sickness and in health. "He gave me a new life. That's the treatment I received—not medicines, but love. He proved that true love doesn't walk away, even when life gets hard.." she wrote. Understanding Guillain-Barré Syndrome (GBS) According to the Mayo Clinic , Guillain-Barré Syndrome is a rare condition where the body's own immune system mistakenly attacks its nerves. The condition often begins with a sensation of tingling or numbness in the hands and feet. This feeling can rapidly worsen, leading to muscle weakness and, in severe cases, full-body paralysis. GBS is considered a medical emergency, and most patients require hospitalization. Though its exact cause remains unknown, in about two-thirds of cases, the onset of GBS is preceded by an infection — such as a respiratory or gastrointestinal illness, and sometimes even COVID-19 or the Zika virus. The progression of symptoms can be swift. Initial indicators may involve: Tingling or a "pins and needles" sensation in fingers, toes, ankles, or wrists. Muscle weakness, beginning in the legs and potentially spreading to the upper body. Difficulty with walking, balance, or climbing stairs. Problems with facial expressions, chewing, or speaking. Double vision or eye movement challenges. Severe nerve pain that may worsen at night. Complications with bladder or bowel control. Irregular heartbeat or unstable blood pressure. Respiratory issues that can become life-threatening. Due to the serious and unpredictable nature of GBS, early detection and immediate medical attention are crucial. Recovery can take weeks to months, and some patients may face long-term effects, including limited mobility. Final Thoughts: Love's Resilience This powerful story is not just about survival; it's about an unbreakable bond. In an age where relationships often falter at the first sign of hardship, Varinder's steadfast commitment stands as a moving testament to what love truly means. He didn't just stand by her in her darkest hour—he pulled her back into life through sheer will and devotion. Their journey offers hope, courage, and a reminder that when love is real, it doesn't run away from storms—it becomes the shelter.
